Breaking News

Your weekly roundup of STAT's First Opinion

 

First Opinion

This week, a baker's dozen essays explored: Force and fear in medicine. The painfully weak evidence that collagen supplements relieve achy knees. Solving staffing shortages in hospitals. And more. You can read them all here. If you have have an idea for First Opinion or want to submit an essay, please send it to first.opinion@statnews.com.

Using force crossed my mind when examining a defiant young patient. A short story made me take a breath

By Christopher Hartnick

NIH/National Library of Medicine

A doctor struggles with using force to look into a resistant patient's mouth. A short story about a patient with diphtheria helped avoid it.

Read More

Researching collagen to help his achy knees, a statistician explores the painfully weak evidence

By Paul T. von Hippel

Adobe

Given the huge market for collagen supplements to treat osteoarthritis, why haven't collagen companies sponsored a large trial of it?

Read More

It's staff, not stuff: Applying crisis standards of care to allocating health care workers

By Cynda Hylton Rushton and Ian Wolfe and Tener Goodwin Veenema

Mario Tama/Getty Images

Crisis standards of care have been developed to allocate scarce resources like ventilators. They now need to encompass health care workers.

Read More

To get to a 'new normal,' public health must focus on all respiratory viruses

By Céline Gounder and Rick A. Bright and Ezekiel J. Emanuel

Adobe

To reach a new normal, the U.S. needs to build programs that guard against all respiratory viruses that pose threats to public health.

Read More

What genetic counselors can teach the CDC about communicating uncertainty

By Chenery Lowe and Liesl Broadbridge and Laynie Dratch

Adobe

Genetic counselors spend their days explaining uncertainty to their clients. The CDC needs to learn how to do that in public communications.

Read More

Is it time for big biopharma companies to rethink the use of federal funding for R&D?

By Kristen Riemenschneider

Adobe

Federal funding for big pharma companies to solve pandemic-related problems points the way to future partnerships on antibiotics and more.

Read More

This HIV prevention medicine is for everyone. Why do so few people take it?

By Kathryn Macapagal

Justin Sullivan/Getty Images

Recent changes in how health care providers should think about PrEP and who it is for have the potential to transform the HIV epidemic.

Read More

New global data showing 1.27 million deaths a year reveal the urgent need to address antimicrobial resistance

By Janet Midega

Wellcome/William R. Geddie

A peer-reviewed paper in The Lancet indicates that 1.27 million deaths a year can be attributed to antimicrobial resistance.

Read More

Covid-19 is no longer the biggest issue facing hospitals. Staffing is

By Dan Michelson

Steven Senne/AP

Staffing and labor challenges were the No. 1 issue health system CEOs and CFOs shared at this year's J.P. Morgan Health Care Conference.

Read More

Fighting Covid-19 in Kibera, one of Africa's largest informal settlements

By Hillary Omala and Eddah Ogogo

Wikimedia Commons

Interest in getting vaccinated is high among residents of Kibera. Getting enough doses for them quickly will be a challenge.

Read More

It's all in the details: start-up packages and ongoing gender bias in academic medicine

By Jennifer Rubin Grandis

Adobe

In academic medicine, the resources in one's start-up package can help explain how gender bias cumulatively disadvantages women in the field.

Read More

Pharmacies shouldn't be the only place to get Paxlovid, the new Covid pill

By Holly Fernandez Lynch and Keith Hamilton

Pfizer

Several states have decided to distribute the Covid-fighting drug Paxlovid to retail pharmacies rather than hospitals. That's a mistake.

Read More

Uncorking today's Covid-19 supply chain to meet the challenges of future pandemics

By Jeff Fischer

Jon Cherry/Getty Images

The U.S. needs a more robust domestic supply chain for better — and quicker — access to testing and other medical supplies.

Read More

Sunday, January 23, 2022

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2022, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us | View In Browser

No comments